Phase 3 Trial Launched to Test Cabometyx-Tecentriq in Advanced Kidney Cancer
https://immuno-oncologynews.com/2020/07/27/exelixis-launches-phase-3-trial-testing-cabometyx-tecentriq-combo-in-advanced-kidney-cancer/
© 2022 Regents of the University of California. All Rights Reserved.